Suppr超能文献

利用 FDA 的 GenomeTrakr 网络进行 SARS-CoV-2 废水变异监测:大流行应对策略。

SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA's GenomeTrakr network.

机构信息

Office of Regulatory Science, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, Maryland, USA.

Gulf Coast Seafood Laboratory, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, Dauphin Island, Alabama, USA.

出版信息

mSystems. 2024 Jun 18;9(6):e0141523. doi: 10.1128/msystems.01415-23. Epub 2024 May 31.

Abstract

UNLABELLED

Wastewater surveillance has emerged as a crucial public health tool for population-level pathogen surveillance. Supported by funding from the American Rescue Plan Act of 2021, the FDA's genomic epidemiology program, GenomeTrakr, was leveraged to sequence SARS-CoV-2 from wastewater sites across the United States. This initiative required the evaluation, optimization, development, and publication of new methods and analytical tools spanning sample collection through variant analyses. Version-controlled protocols for each step of the process were developed and published on protocols.io. A custom data analysis tool and a publicly accessible dashboard were built to facilitate real-time visualization of the collected data, focusing on the relative abundance of SARS-CoV-2 variants and sub-lineages across different samples and sites throughout the project. From September 2021 through June 2023, a total of 3,389 wastewater samples were collected, with 2,517 undergoing sequencing and submission to NCBI under the umbrella BioProject, PRJNA757291. Sequence data were released with explicit quality control (QC) tags on all sequence records, communicating our confidence in the quality of data. Variant analysis revealed wide circulation of Delta in the fall of 2021 and captured the sweep of Omicron and subsequent diversification of this lineage through the end of the sampling period. This project successfully achieved two important goals for the FDA's GenomeTrakr program: first, contributing timely genomic data for the SARS-CoV-2 pandemic response, and second, establishing both capacity and best practices for culture-independent, population-level environmental surveillance for other pathogens of interest to the FDA.

IMPORTANCE

This paper serves two primary objectives. First, it summarizes the genomic and contextual data collected during a Covid-19 pandemic response project, which utilized the FDA's laboratory network, traditionally employed for sequencing foodborne pathogens, for sequencing SARS-CoV-2 from wastewater samples. Second, it outlines best practices for gathering and organizing population-level next generation sequencing (NGS) data collected for culture-free, surveillance of pathogens sourced from environmental samples.

摘要

未加标签

污水监测已成为人群水平病原体监测的重要公共卫生工具。在美国 2021 年《美国救援计划法案》的支持下,食品和药物管理局的基因组流行病学计划 GenomeTrakr 被利用来对美国各地污水站点的 SARS-CoV-2 进行测序。这项倡议需要评估、优化、开发和发布新的方法和分析工具,涵盖从样本采集到变体分析的各个环节。针对该过程的每一步骤,均开发了带版本控制的协议,并在 protocols.io 上发布。还构建了一个自定义数据分析工具和一个公共可访问的仪表板,以实时可视化收集的数据,重点关注项目过程中不同样本和地点的 SARS-CoV-2 变体和亚谱系的相对丰度。从 2021 年 9 月到 2023 年 6 月,共采集了 3389 个污水样本,其中 2517 个样本经过测序,并在 BioProject 下提交给 NCBI,项目编号 PRJNA757291。所有序列记录都带有明确的质量控制 (QC) 标签发布序列数据,传达了我们对数据质量的信心。变体分析显示,Delta 在 2021 年秋季广泛传播,并捕捉到了 Omicron 的横扫以及该谱系在采样结束时的多样化。该项目成功实现了食品和药物管理局 GenomeTrakr 计划的两个重要目标:首先,为 SARS-CoV-2 大流行应对提供及时的基因组数据;其次,为食品和药物管理局关注的其他病原体建立独立于培养的、人群水平的环境监测能力和最佳实践。

重要性

本文有两个主要目标。首先,它总结了在利用食品和药物管理局的实验室网络(传统上用于测序食源性病原体)对污水样本中的 SARS-CoV-2 进行测序的新冠疫情应对项目中收集的基因组和背景数据。其次,它概述了从环境样本中收集无培养、用于病原体监测的人群水平下一代测序 (NGS) 数据的最佳实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deb9/11326115/eac1d174b7b5/msystems.01415-23.f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验